Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPreclinical Probes for Oncology

Radiochemistry, biodistribution and imaging study of 161Tb and 155Tb labeled crown-αMSH for MC1R targeting theranostics

Luke Wharton, Scott McNeil, Gokce Engudar, Chengcheng Zhang, Michiel Van de Voorde, Maarten Ooms, Peter Kunz, Francois Benard, Valery Radchenko and Hua Yang
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2356;
Luke Wharton
1TRIUMF Life Sciences Division
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott McNeil
2TRIUMF
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gokce Engudar
2TRIUMF
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chengcheng Zhang
3BC Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michiel Van de Voorde
4SCK CEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maarten Ooms
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Kunz
2TRIUMF
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Benard
5BC Cancer Research Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valery Radchenko
2TRIUMF
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hua Yang
2TRIUMF
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiochemistry, biodistribution and imaging study of 161Tb and 155Tb labeled crown-αMSH for MC1R targeting theranostics
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiochemistry, biodistribution and imaging study of 161Tb and 155Tb labeled crown-αMSH for MC1R targeting theranostics
Luke Wharton, Scott McNeil, Gokce Engudar, Chengcheng Zhang, Michiel Van de Voorde, Maarten Ooms, Peter Kunz, Francois Benard, Valery Radchenko, Hua Yang
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2356;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiochemistry, biodistribution and imaging study of 161Tb and 155Tb labeled crown-αMSH for MC1R targeting theranostics
Luke Wharton, Scott McNeil, Gokce Engudar, Chengcheng Zhang, Michiel Van de Voorde, Maarten Ooms, Peter Kunz, Francois Benard, Valery Radchenko, Hua Yang
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2356;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Preliminary Investigation of 43Sc/47Sc-DOTATATE for Theranostic Applications
  • Design of cleavable linkers for Antibody Drug Conjugates and evaluation of stability using radioimmunoconjugates
  • Diagnostic efficacy of 68Ga-DOTAGA-Duramycin for detection of doxorubicin induced organ toxicity in Wistar rats
Show more Preclinical Probes for Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire